[1] [1] Baranova I, Iliuk I, Leshchenko S, et al. Modern aspects of diagnostics and treatment of post-infectious cough hypersensitivity syndrome[J]. Cough, 2020, 19: 37.

[4] [4] Jiang W, Qi J, Li X, et al. Post-infectious cough of different syndromes treated by traditional chinese medicines: a review[J]. Chin Herb Med, 2022, 14(4): 494-510.

[5] [5] Lu H, Cao P. Neural mechanisms underlying the coughing reflex[J]. Neurosci Bull, 2023, 39(12): 1823-1839.

[6] [6] Hao YL, Yang ZF, Shang JH, et al. Effects of indole alkaloids from leaf of Alstonia scholaris on post-infectious cough in mice[J]. J Ethnopharmacol, 2018, 218: 69-75.

[7] [7] Lai K, Lin L, Liu B, et al. Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection[J]. Respirology, 2016, 21(4): 683-688.

[9] [9] Sun J, Zhan C, Deng Z, et al. Expression of interferon- and its effect on cough hypersensitivity in chronic refractory cough patients[J]. Thorax, 2022, 77(6): 621-624.

[10] [10] Deng Z, Ding W, Li F, etal. Pulmonary IFN- causes lymphocytic inflammation and cough hypersensitivity by increasing the number of IFN--secreting T lymphocytes[J]. Allergy Asthma Immunol Res, 2022, 14(6): 653-673.

[13] [13] Yang J. Mechanism of azithromycin in airway diseases[J]. J Int Med Res, 2020, 48(6): 300060520932104.

[14] [14] Al-Shamlan F, El-Hashim AZ. Bradykinin sensitizes the cough reflex via a B2receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase[J]. Respir Res, 2019, 20(1): 110.

[15] [15] Li Y, Zhao R, Zhang M, et al. Xingbei antitussive granules ameliorate cough hypersensitivity in post-infectious cough guinea pigs by regulating tryptase/PAR2/TRPV1 pathway[J]. J Ethnopharmacol, 2024, 319: 117243.

[17] [17] Kim YC, Song WJ. Neuro-immune interactions and IFN- in post-infectious cough[J]. Allergy Asthma Immunol Res, 2022, 14(6): 581-584.

[18] [18] Chung KF, Mcgarvey L, Song WJ, et al. Cough hypersensitivity and chronic cough[J]. Nat Rev Dis Primers, 2022, 8(1): 45.

[19] [19] Voynow JA, Shinbashi M. Neutrophil elastase and chronic lung disease[J]. Biomolecules, 2021, 11(8): 1065.

[20] [20] Rouadi PW, Idriss SA, Bousquet J, et al. WAO-ARIA consensus on chronic cough—Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways[J]. World Allergy Organ J, 2021, 14(12): 100617.

[21] [21] Schiffers C, Hristova M, Habibovic A, et al. The transient receptor potential channel vanilloid 1 is critical in innate airway epithelial responses to protease allergens[J]. Am J Respir Cell Mol Biol, 2020, 63(2): 198-208.

[22] [22] Li T, Wang G, Hui V CC, et al. TRPV1 feed-forward sensitisation depends on COX2 upregulation in primary sensory neurons[J]. Sci Rep, 2021, 11(1): 3514.

[23] [23] Pierre O, Fouchard M, Buscaglia P, et al. Calcium increase and substance P release induced by the neurotoxin brevetoxin-1 in sensory neurons: involvement of PAR2 activation through both cathepsin S and canonical signaling[J]. Cells, 2020, 9(12): 2704.

[24] [24] Chandrabalan A, Ramachandran R. Molecular mechanisms regulating proteinase-activated receptors(PARs)[J]. FEBS J, 2021, 288(8): 2697-2726.

[25] [25] Sun J, Zhan C, Deng Z, et al. Expression of interferon- and its effect on cough hypersensitivity in chronic refractory cough patients[J]. Thorax, 2022, 77(6): 621-624.

[26] [26] Landini L, Souza Monteiro De Araujo D, Titiz M, et al. TRPA1 role in inflammatory disorders: what is known so far?[J]. Int J Mol Sci, 2022, 23(9): 4529.

[27] [27] Song WJ, Chung KF. Pharmacotherapeutic options for chronic refractory cough[J]. Expert Opin Pharmacother, 2020, 21(11): 1345-1358.

[28] [28] Janach GMS, Reetz O, Dohne N, et al. Interferon- acutely augments inhibition of neocorticallayer 5 pyramidal neurons[J]. J Neuroinflammation, 2020, 17(1): 69.

[29] [29] Sun J, Zhan C, Deng Z, et al. Expression of interferon- and its effect on cough hypersensitivity in chronic refractory cough patients[J]. Thorax, 2022, 77(6): 621-624.

[31] [31] Ding W, Xu D, Li F, et al. Intrapulmonary IFN- instillation causes chronic lymphocytic inflammation in the spleen and lung through the CXCR3 pathway[J]. Int Immunopharmacol, 2023, 122: 110675.

[32] [32] Pavon-Romero GF, Serrano-Perez NH, Garcia-Sanchez L, et al. Neuroimmune pathophysiology in asthma[J]. Front Cell Dev Biol, 2021, 9: 663535.

[33] [33] Zhuang J, Gao X, Zhao L, et al. Neurokinin 1 and 2 receptors are involved in PGE2-and citric acid-induced cough and ventilatory responses[J]. Respir Physiol Neurobiol, 2022, 306: 103952.

[34] [34] Jia W, Wang W, Li R, et al. Effect of Qinbai Qingfei Concentrated Pellets on substance P and neutral endopeptidase of rats with post-infectious cough[J]. BMC Complement Med Ther, 2020, 20(1): 289.

[36] [36] Xu Y, Cao S, Wang SF, etal. Zhisou powder suppresses airway inflammation in LPS and CS-induced post-infectious cough model mice via TRPA1/TRPV1 channels[J]. J Ethnopharmacol, 2024, 324: 117741.

[39] [39] Luo J, Deng Y, Ding Y, et al. Investigation into actions of Xiebai and Zengye decoction on cough sensitivity, airway inflammation and gut microbiota in the rat model of post-infectious cough[J]. Heliyon, 2023, 9(12): e22782.

[40] [40] Sulaiman I, Wu BG, Chung M, et al. Lower airway dysbiosis augments lung inflammatory injury in mild-to-moderate chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2023, 208(10): 1101-1114.

[41] [41] Kopcova L, Matloobi A, Biringerova Z, et al. Cough response in specific pathogen-free guinea pig animal model[J]. Respir Physiol Neurobiol, 2023, 313: 104067.

[42] [42] Han YL, Peng XM, Zhang HX, et al. Electroacupuncture regulates TRPV1 through PAR2/PKC pathway to alleviate visceral hypersensitivity in FD rats[J]. Evid Based Complement Alternat Med, 2021, 2021(1): 1975228.

[44] [44] Green DP, Limjunyawong N, Gour N, et al. A mast-cell-specific receptor mediates neurogenic inflammation and pain[J]. Neuron, 2019, 101(3): 412-420.

[45] [45] Mrozkova P, Spicarova D, Palecek J. Spinal PAR2 activation contributes to hypersensitivity induced by peripheral inflammation in rats[J]. Int J Mol Sci, 2021, 22(3): 991.

[46] [46] Luo J, Deng Y, Ding Y, et al. Xiebai Zengye decoction improves respiratory function and attenuates inflammation in juvenile rats with postinfection cough via regulating ERK signaling pathway[J]. Cell Biochem Funct, 2023, 41(7): 857-867.

[48] [48] Larigot L, Juricek L, Dairou J, et al. AhR signaling pathways and regulatory functions[J]. Biochimie Open, 2018, 7: 1-9.

[49] [49] Shivanna B, Chu C, Moorthy B. The aryl hydrocarbon receptor(AhR): a novel therapeutic target for pulmonary diseases?[J]. Int J Mol Sci, 2022, 23(3): 1516.

[50] [50] Ngo V, Duennwald ML, Ngo V, et al. Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease[J]. Antioxidants, 2022, 11(12): 2345.

[51] [51] Tsuji G, Takahara M, Uchi H, et al. Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: the basis of its anti-inflammatory effect[J]. J Invest Dermatol, 2012, 132(1): 59-68.

[52] [52] Esakky P, Hansen DA, Drury AM, et al. Modulation of cell cycle progression in the spermatocyte cell line[GC-2spd(ts)cell-line]by cigarette smoke condensate(CSC)via arylhydrocarbon receptor-nuclear factor erythroid 2-related factor 2(AhR-Nrf2)pathway[J]. Biol Reprod, 2014, 90(1): 9.

[53] [53] Liang R, Tong X, Dong Z, et al. Suhuang antitussive capsule ameliorates post-infectious cough in mice through AhR-Nrf2 pathway[J]. J Ethnopharmacol, 2022, 283: 114664.

[54] [54] Hayes JD, Dinkova-Kostova AT, Mcmahon M. Cross-talk between transcription factors AhR and Nrf2: lessons for cancer chemoprevention from dioxin[J]. Toxicol Sci, 2009, 111(2): 199-201.

[55] [55] Cheng Y, Wang D, Wang B, etal. HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway[J]. Mol Biol Cell, 2017, 28(1): 201-209.

[58] [58] Kamei J, Matsunawa Y, Saitoh A. Antitussive effect of NS-398, a selective cyclooxygenase-2 inhibitor, in guinea pigs[J]. Eur J Pharmacol, 2004, 497(2): 233-239.

[59] [59] Liviero F, Campisi M, Mason P, et al. Transient receptor potential vanilloid subtype 1: potential role in infection, susceptibility, symptoms and treatment of COVID-19[J]. Front Med(Lausanne), 2021, 8: 753819.

[61] [61] El-Hashim AZ, Jaffal SM. Nerve growth factor enhances cough and airway obstruction via TrkA receptor-and TRPV1-dependent mechanisms[J]. Thorax, 2009, 64(9): 791-797.